Consistent with published evidence that the RELN gene is repressed or silenced in breast cancer [23], transfection with a reporter gene construct in which a minimal RELN promoter drives luciferase expression showed that RELN promoter activity was significantly higher in α3-KD MDA-MB-231 cells, compared with control cells. The gene discussed is RELN; the disease is breast carcinoma.